KRAS and cancer: Moreover, in both in vitro and in vivo models, KRAS G12C decreased the levels of glutamine and glutamate, two amino acids involved in nitrogen balance maintenance, supporting the central role of glutaminolysis and nitrogen anabolism to provide energy for cancer cell growth and proliferation.